Korean native species are the first to be registered in the U.S. herbal medicine standard book, and this ingredient helps prevent aging and dementia
Jul 20, 2025
|
The Korea Food and Drug Safety Evaluation Institute of the Ministry of Food and Drug Safety said in a joint study with the U.S. Pharmaceutical Commission (USP) that Angelica gigas, a native species in Korea, were first listed in the USP's US Biopharmaceutical Standards (HMC).
The Herbal Medicines Compendium (HMC) is a standard for reference to quality standards for biopharmaceuticals in the United States, and the listing will recognize that the quality of the raw material has been secured when a product containing Angelica gigas, a raw material such as Hwangcheongsimwon (stroke), and Forsythia suspensa, a raw material such as silver kyo acid (cough, headache), is exported to the United States.
Chamgwi is a plant belonging to the Minari family and is widely used to improve various women's diseases such as anemia, poor complexion, prenatal and postpartum recovery, menstrual irregularities, and poor uterine development.
Decursin and decursinol Angelate, which are representative substances of Chamdanggui, are attracting attention for their help in preventing anti-aging and dementia. In addition, studies have shown that it is effective in preventing and improving vascular diseases such as arteriosclerosis by reducing blood cholesterol levels. In addition, it is known that it has a positive effect on blood cancers such as leukemia due to the high proportion of coumarin-based ingredients such as decurcin. It is widely used to improve various women's diseases such as anemia, poor complexion, prenatal and postpartum recovery, menstrual irregularities, and uterine development by helping blood production (blood retention) and blood circulation (active blood).
Kim Hyun-jung, director of the Natural Pharmaceutical R&D Center, Kwangdong Pharmaceutical Co., Ltd., said "Chamdanggui, a traditionally widely used domestic native species, is a representative item that is widely used as a raw material for herbal medicines, so we expect this listing to be a priming water for revitalizing the herbal medicine industry and to be of great help in entering the U.S. market."
Director of Korea Food and Drug Safety Evaluation Kang Seok-yeon said, `We will do our best to support entry into the U.S. market while ensuring the international quality of domestic herbal medicines through communication with domestic industries trying to export products to the U.S. and continuous registration of domestic herbal ingredients" he said.
This article was translated by Naver AI translator.
